BETA: Please send your feedback!
Bristol-Myers Squibb
BMY:NYS
Pharmaceuticals: Major
$0
MEGA cap
$58.25
(1.35%)
-0.06%
since start of 2020
26.47
About
Pharmaceuticals: Major
Founded 1933
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.
website
Headquarters
Executives
| Name | Title | Gender |
| Sandra Leung | Executive Vice President & General Counsel | Female |
| John E. Elicker, MBA | Senior VP-Public Affairs & Investor Relations | Male |
| Thomas James Lynch, Jr., MD | Chief Scientific Officer & Executive VP | Male |
| Charles A. Bancroft, MBA, CPA | CFO, EVP & Head-Global Business Operations | Male |
| Paul von Autenried | Chief Information Officer & Senior Vice President | Male |
| Giovanni Caforio, MD | Chairman & Chief Executive Officer | Male |
| Ann Powell Judge | Chief Human Resources Officer & Senior VP | Female |
Mindful Investing Summary
Bristol-Myers Squibb - Competitors and Related Companies
How Bristol-Myers Squibb stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.
Bristol-Myers Squibb
BMY:NYS
Pharmaceuticals: Major
$0
MEGA cap
$58.25
(1.35%)
-0.06%
since start of 2020
26.47
AbbVie
ABBV:NYS
Pharmaceuticals: Major
$116.01bn
MEGA cap
$78.56
(3.17%)
-0.08%
since start of 2020
14.83
Eli Lilly
LLY:NYS
Pharmaceuticals: Major
$139.94bn
MEGA cap
$146.22
(4.34%)
0.11%
since start of 2020
29.13
Johnson & Johnson
JNJ:NYS
Pharmaceuticals: Major
$377.68bn
MEGA cap
$143.26
(5.78%)
-0.02%
since start of 2020
25.08
Merck
MRK:NYS
Pharmaceuticals: Major
$207.01bn
MEGA cap
$81.62
(3.06%)
-0.10%
since start of 2020
21.26
Novartis
NOVN-CH:SWX
Pharmaceuticals: Major
$10.38mm
MEGA cap
$0.38
(0.02%)
-0.83%
since start of 2020
-0.32